In yesterday’s Wall Street session, R1 RCM Inc. (NASDAQ:RCM) shares traded at $13.75, down -1.79% from the previous session.
RCM stock price is now -16.10% away from the 50-day moving average and -10.32% away from the 200-day moving average. The market capitalization of the company currently stands at $5.76B.
With the price target of $20, Citigroup recently initiated with Buy rating for R1 RCM Inc. (NASDAQ: RCM).
In other news, HENNEMAN JOHN B III, Director sold 50,000 shares of the company’s stock on Aug 08. The stock was sold for $858,650 at an average price of $17.17. Upon completion of the transaction, the Director now directly owns 72,114 shares in the company, valued at $0.99 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 12, Principal Accounting Officer Evans Richard B. Jr. sold 17,000 shares of the business’s stock. A total of $286,229 was realized by selling the stock at an average price of $16.84. This leaves the insider owning 124,007 shares of the company worth $1.71 million. Insiders disposed of 526,078 shares of company stock worth roughly $7.23 million over the past 1 year. A total of 54.11% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in RCM stock. A new stake in R1 RCM Inc. shares was purchased by MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. during the first quarter worth $9,211,000. FARALLON CAPITAL MANAGEMENT LLC invested $7,590,000 in shares of RCM during the first quarter. In the first quarter, UNISUPER MANAGEMENT PTY LTD acquired a new stake in R1 RCM Inc. valued at approximately $6,518,000. BALYASNY ASSET MANAGEMENT L.P. acquired a new stake in RCM for approximately $3,775,000. SHELTON CAPITAL MANAGEMENT purchased a new stake in RCM valued at around $2,985,000 in the second quarter. In total, there are 331 active investors with 38.78% ownership of the company’s stock.
During the past 12 months, R1 RCM Inc. has had a low of $6.71 and a high of $19.44. As of last week, the company has a debt-to-equity ratio of 0.68, a current ratio of 1.80, and a quick ratio of 1.80. The fifty day moving average price for RCM is $16.33 and a two-hundred day moving average price translates $15.35 for the stock.
The latest earnings results from R1 RCM Inc. (NASDAQ: RCM) was released for Jun, 2023. According to the Health Information Services Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.07 EPS in the same period last year. The net profit margin was -3.09% and return on equity was -2.40% for RCM. The company reported revenue of $560.7 million for the quarter, compared to $391.9 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 43.07 percent. For the current quarter, analysts expect RCM to generate $570.5M in revenue.
R1 RCM Inc.(RCM) Company Profile
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.
